B-Cell CLL/lymphoma 7A (BCL7A) (Middle Region) Peptide
BCL7A
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all BCL7A products
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
- 蛋白结构域
- Middle Region
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 序列
- CGSEVTTPEN SSSPGMMDMH DDNSNQSSIA DASPIKQENS SNSSPAPEPN
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-BCL7A Antibody(ARP57507_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
B-Cell CLL/lymphoma 7A (BCL7A) peptide
BCL7A 适用: 人, Cow, 犬, 小鼠, Pig, 大鼠 宿主: 合成 BP, Imm
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
- 背景
-
This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: BCL7
Protein Interaction Partner: RELB,RELB
Protein Size: 231 - 分子量
- 25 kDa
- 基因ID
- 605
- NCBI登录号
- NM_020993, NP_066273
- UniProt
- Q4VC05
-
You are here:
